Dr. Evans is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Main Line Oncology Hematology Associates
100 Lancaster Avenue
Wynnewood, PA 19096Phone+1 610-645-2495Fax+1 610-645-4456- Is this information wrong?
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1999 - 2002
- Brigham and Women's HospitalInternship, Internal Medicine, 1996 - 1997
- Perelman School of Medicine at the University of PennsylvaniaClass of 1996
Certifications & Licensure
- PA State Medical License 2002 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Philadelphia Magazine Castle Connolly, 2012-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 1 citationsPhase II Trial of Combination Nab-paclitaxel and Gemcitabine in Non-squamous Non-small Cell Lung Cancer After Progression on Platinum and Pemetrexed.Christine A Ciunci, Jacob B Reibel, Tracey L Evans, Rosemarie Mick, Joshua M Bauml, Charu Aggarwal, Melina E Marmarelis, Aditi P Singh, Christopher D'Avella, Roger B C...> ;Clinical Lung Cancer. 2022 Jun 1
- Optimal prescription isodose line in SBRT for lung tumor treatment with volumetric-modulated arc therapy.David Wang, Albert S. DeNittis, Tracey L. Evans, Thomas Meyer> ;Journal of Radiosurgery and SBRT. 2020 Jan 1
- 20 citationsClinical Outcomes of the HIV Protease Inhibitor Nelfinavir With Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non–Small Cell Lung Cancer: A Phase 1/2 T...Ramesh Rengan, Rosemarie Mick, Daniel A. Pryma, Lilie Leming Lin, John P. Christodouleas, John P. Plastaras, Charles B. Simone, Anjali K. Gupta, Tracey L. Evans, James...> ;JAMA Oncology. 2019 Oct 1
- Join now to see all
Press Mentions
- Optimal Role of PD-L1 Still Unclear in NSCLCOctober 6th, 2016
- What to Do After Progression on Immunotherapy and for Non-Driver NSCLCApril 5th, 2017
- Can Big Data Help Cancer Patients Avoid ER Visits?January 30th, 2017
- Join now to see all
Hospital Affiliations
- Lankenau Medical CenterWynnewood, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: